North Haven Venture Capital Opportunities Fund II LP

The presence of Morgan Stanley AIP GP LP as a named GP signals institutional co-investment or LP-seeded capital alongside the three named principals (Candy, Miller, Auffenberg), a structure that often indicates the manager is either scaling via an anchor institution or has embedded Morgan Stanley as a strategic capital provider, which differs materially from a traditional independent GP raise.

A mid-2026 filing for a Series II vintage aligns with the 3-to-4-year cycle of a Fund I deployment window closing; this timing is standard post-Series I follow-on activity, though the placeholder status means the manager is locking legal entities ahead of market conditions rather than launching into immediate LP marketing.

Verify whether Derek Candy, Agne Miller, or Christopher Auffenberg carry key-person provisions tied to specific investment roles, and confirm the allocation of GP commitment and carry between the three principals and Morgan Stanley AIP—this split structure can create misalignment if not clearly documented in the LPA, especially in a succession vehicle where continuity assumptions matter.